Drug profile · INN
avutometinib potassium
AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)
avutometinib potassium (AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)) is an FDA-listed pharmaceutical active ingredient. Associated with Vera Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Drug details — avutometinib potassium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 6
- Data quality
- 0.89
Quick answer
avutometinib potassium (AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)) is an FDA-listed pharmaceutical active ingredient. Associated with Vera Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Congress & event coverage
Pipeline programs
Related patents
-
US 12257288
Methods of inducing immune tolerance to clotting factors
granted -
US 12173307
Methods for the purification of viral vectors
granted -
US 12059400
Medical compound
granted -
US 12030925
Methods of treating hemophilia A
granted -
US 12005220
Microneedle patch for immunostimulatory drug delivery
granted -
US 11877989
Nutritional supplement containing L-α-glycerophosphorylcholine
granted -
US 11873296
Solid forms of a dual RAF/MEK inhibitor
granted -
US 11753461
Optimized factor VIII genes
granted -
US 11639527
Methods for nucleic acid sequencing
granted -
US 11372008
Blood factor monitoring assay and uses thereof
granted -
US 11261437
Procoagulant compounds
granted -
US 11229600
Compositions and methods for selective GI tract delivery
granted -
US 11225650
Methods of using FIX polypeptides
granted -
US 11192944
Methods of inducing complement activity
granted -
US 11091534
Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof
granted -
US 10947170
Process for the preparation of deuterated ethanol from D2O
granted -
US 10940208
Nanoassembled complexes of nucleic acids, avidin and biotinylated compounds for use as drug carriers
granted -
US 10927362
Processable single chain molecules and polypeptides made using same
granted -
US 10898554
Factor IX polypeptides and methods of use thereof
granted -
US 10751343
Nasal compositions stimulating ciliary activity
granted
Frequently asked questions
What is avutometinib potassium?
avutometinib potassium (AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)) is an FDA-listed pharmaceutical active ingredient. Associated with Vera Therapeutics. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for avutometinib potassium?
AVMAPKI FAKZYNJA CO-PACK (COPACKAGED) is a marketed brand name for avutometinib potassium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of avutometinib potassium?
avutometinib potassium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.